Search

Author/Creator Chung, M K

2. Cardiovascular benefits outweigh risks in patients with atrial fibrillation in REDUCE-IT (Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial). (14th October 2021)

Authors:
Olshansky, B; Bhatt, D; Miller, M; Steg, P G; Brinton, E A; Jacobson, T A; Ketchum, S B; Doyle Jr, R T; Juliano, R A; Jiao, L; Kowey, P; Reiffel, J A; Tardif, J.-C; Ballantyne, C M; Chung, M K
Journal:
European heart journal
Issue:
Volume 42(2021)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies. Issue 2 (27th May 2005)

Authors:
Verma, A; Kilicaslan, F; Martin, D O; Minor, S; Starling, R; Marrouche, N F; Almahammed, S; Wazni, O M; Duggal, S; Zuzek, R; Yamaji, H; Cummings, J; Chung, M K; Tchou, P J; Natale, A
Journal:
Heart
Issue:
Volume 92:Issue 2(2006)
Page Start:
190
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗